Your browser doesn't support javascript.
loading
Metformin induces distinct bioenergetic and metabolic profiles in sensitive versus resistant high grade serous ovarian cancer and normal fallopian tube secretory epithelial cells.
Hodeib, Melissa; Ogrodzinski, Martin P; Vergnes, Laurent; Reue, Karen; Karlan, Beth Y; Lunt, Sophia Y; Aspuria, Paul-Joseph P.
Affiliation
  • Hodeib M; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Ogrodzinski MP; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824, USA.
  • Vergnes L; Department of Physiology, Michigan State University, East Lansing, MI 48824, USA.
  • Reue K; Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
  • Karlan BY; Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
  • Lunt SY; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Aspuria PP; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824, USA.
Oncotarget ; 9(3): 4044-4060, 2018 Jan 09.
Article in En | MEDLINE | ID: mdl-29423103
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Oncotarget Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Oncotarget Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States